Glassy cell carcinoma of the cervix: report of a case and literature review

被引:0
作者
Hakimi, Ihssane [1 ]
Zazi, Abdelghani [1 ]
Chahdi, Hafsa [2 ]
Guelzim, Khalid [1 ]
Kouach, Jaouad [1 ]
Babahabib, Myabdellah [1 ]
Elhassani, Myehdi [1 ]
Rahali, Driss Moussaoui [1 ]
Dehayni, Mohammed [1 ]
机构
[1] Hop Mil Instruct Mohammed V, Serv Gynecol Obstet, Rabat, Morocco
[2] Hop Mil Instruct Mohammed V, Serv Anat Pathol, Rabat, Morocco
来源
PAN AFRICAN MEDICAL JOURNAL | 2015年 / 22卷
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页数:4
相关论文
共 27 条
[1]  
Alfsen GC, 2000, CANCER, V89, P1291, DOI 10.1002/1097-0142(20000915)89:6<1291::AID-CNCR14>3.0.CO
[2]  
2-O
[3]   Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix [J].
Duenas-Gonzalez, Alfonso ;
Zarba, Juan J. ;
Patel, Firuza ;
Alcedo, Juan C. ;
Beslija, Semir ;
Casanova, Luis ;
Pattaranutaporn, Pittayapoom ;
Hameed, Shahid ;
Blair, Julie M. ;
Barraclough, Helen ;
Orlando, Mauro .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (13) :1678-1685
[4]   Conservatively treated glassy cell carcinoma of the cervix [J].
Ferrandina, Gabriella ;
Salutari, Vanda ;
Petrillo, Marco ;
Carbone, Arnaldo ;
Scambia, Giovanni .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2008, 6 (1)
[5]  
FU YS, 1982, CANCER, V49, P2560, DOI 10.1002/1097-0142(19820615)49:12<2560::AID-CNCR2820491225>3.0.CO
[6]  
2-G
[7]  
GLUCKSMANN A, 1956, CANCER, V9, P971, DOI 10.1002/1097-0142(195609/10)9:5<971::AID-CNCR2820090518>3.0.CO
[8]  
2-T
[9]   Glassy cell carcinoma of the cervix revisited [J].
Gray, HJ ;
Garcia, R ;
Tamini, HK ;
Koh, WJ ;
Goff, BA ;
Greer, BE ;
Paley, PJ .
GYNECOLOGIC ONCOLOGY, 2002, 85 (02) :274-277
[10]   A case of glassy cell carcinoma of the uterine cervix effectively responding to chemotherapy with paclitaxel and carboplatin [J].
Hirashima, Y ;
Kobayashi, H ;
Nishiguchi, T ;
Miura, K ;
Kanayama, N .
ANTI-CANCER DRUGS, 2001, 12 (07) :627-630